NCT01804101 2018-05-25Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid LeukemiaFred Hutchinson Cancer CenterPhase NA Completed48 enrolled 9 charts